| 发明名称 |
HEXADECYLOXYPROPYL CIDOFOVIR FOR THE TREATMENT OF DOUBLE-STRANDED DNA VIRUS INFECTION |
| 摘要 |
The present application provides methods and compositions for treatment or prevention of dsDNA virus infection in post-hematopoietic cell transplant (HCT or HSCT) patients. |
| 申请公布号 |
US2014303092(A1) |
申请公布日期 |
2014.10.09 |
| 申请号 |
US201214354481 |
申请日期 |
2012.10.26 |
| 申请人 |
CHIMERIX, INC. |
发明人 |
Painter George R.;Lanier Ernest Randall;Almond Merrick R.;Margolskee Dorothy;Painter Gwendolyn Powell |
| 分类号 |
C07F9/6512;A61K45/06;A61K31/675 |
主分类号 |
C07F9/6512 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treatment, prevention, or delaying on-set of cytomegalovirus (CMV) infection or a CMV infection associated disease or disorder, the method comprising orally administering to a subject a pharmaceutical composition comprising a therapeutically effective dose of a compound selected from: and a pharmaceutically acceptable salt thereof, wherein said subject is a post-hematopoietic stem cell transplant (HSCT) subject and is CMV seropositive before transplantation. |
| 地址 |
Durham NC US |
